DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") is pleased to announce that Health Canada has approved the Company's application for an amendment to its cannabis production and sale license which will allow it to produce bottled cannabis oils under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). The license amendment was issued on April 20, 2018 and is valid until August 30, 2019. "This is another important step for Delta 9 in preparing for legalization in Canada, but also in working with our partners in Germany, where we have signed an export agreement," said Delta 9 CEO John Arbuthnot.

Delta 9 announced the signing of a non-binding letter of intent on March 27, 2018 with Global Group Kalapa S.L. and Canpharma GMBH for the exportation of medical cannabis and cannabis oils to Germany. As part of that agreement, Delta 9 agreed to produce cannabis oil, and agreed to become GMP (Good Manufacturing Process) certified.

Also this week Delta 9 engaged QNR Associates of Edmonton, Alberta to help plan the upgrade of the Company's Winnipeg facility to the standards required of GMP certification. Currently the facility is certified under the GPP (Good Production Practices) protocol, which is required under the ACMPR program in Canada.

The Company also recently announced that it is building a second cannabis production facility in Calgary, Alberta in partnership with Westleaf Cannabis Inc., known as the "Delta West" facility. This facility will include a GMP certified lab for the production of cannabis oil and all legally allowed cannabis extracts and derivatives.

This month Delta 9 also submitted its application for cannabis retail outlets in Saskatchewan under the Provincial Government's RFP process, which closed on April 10, 2018.

"Our management believes there is a strong and generally underserved market in the Prairie Provinces, and we have focused our goals on becoming a market leader in Manitoba, Saskatchewan and Alberta," said Arbuthnot. "Our expansion in all of these provinces is actually proceeding faster than expected, and obtaining our license for cannabis oils was one more crucial step on our path."